The levels of osteoprotegerin, transforming growth factor-β, and some cytokines in women with coronary heart disease concurrent with severe osteoporosis
- 作者: Tsarenok SY.1, Gorbunov VV1
-
隶属关系:
- 期: 卷 87, 编号 9 (2015)
- 页面: 39-43
- 栏目: Editorial
- ##submission.dateSubmitted##: 10.04.2020
- ##submission.datePublished##: 15.09.2015
- URL: https://ter-arkhiv.ru/0040-3660/article/view/31801
- ID: 31801
如何引用文章
全文:
详细
Aim. To determine the serum level of cytokines in women with coronary heart disease (CHD) concurrent with osteoporosis (OP) and in those with isolated CHD; to assess a relationship of the levels of cytokines, osteoprotegerin (OPG), and transforming growth factor-β (TGF-β) to the ten-year absolute risk of osteoporotic fractures, the presence of fractures in the history, and that of CHD; and to establish the role of elevated cytokine levels in the development of future fractures. Subjects and methods. A cross-sectional cohort study included 98 women (mean age, 71.2±8.6 years) with CHD. Forty-eight patients had CHD concurrent with severe OP. The Fracture Risk Assessment Tool (FRAX) was applied to estimate a ten-year absolute risk for fractures in all the patients. The serum levels of OPG, TGF-β, interleukin (IL)-1β, IL-4, IL-6, IL-8, and IL-10, and tumor necrosis factor-α (TNF-α) were measured by enzyme immunoassay. Results. The women with comorbidity were found to have higher levels of OPG, TGF-β, IL-6, IL-8, IL-10, and TNF-α than those with isolated CHD. There was a direct correlation between fractures, CHD, and IL-10 and TNF-α levels and an inverse relationship between fractures, CHD, and IL-8; between CHD and OPG levels. Conclusion. The women with comorbidity were noted to have elevated levels of proinflammatory cytokines and OPG; a correlation was between cytokine levels and fractures and CHD. Increased OPG and IL-6 levels are independent predictors of fractures.
参考
- Browner WS, Sooley DG, Vogt TM. Non-trauma mortality in elderly women with low bone mineral density. Lancet. 1991;338:335-338.
- Diamond TH, Thornley SW, Sekel R, Smerdely P. Hip frature in Elderly Man: Prognostic Factors and Outcomes. Med J Australia. 1997;167(8):412-415.
- Uyama O, Yoshimoto Y, Yamamoto Y, Kawai A. Bone changes and carotid atherosclerosis in postmenopausal women. Stroke. 1997;28:1730-1732.
- Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 1997;17:680-687.
- Pahmani F, Garfinkel A, Demer LL. Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol. 2000;20:2346-2348.
- Bucay N, Sarosi I, Dunstan CR , Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998;12(9):1260-1268.
- Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-p and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest. 1994;93:2106-2113.
- Heinisch RH, Zanetti CR, Comin F. Infflammatory cytokines predict one-year outcome of patient with acute coronary syndromes but not in stable angina. Eur Heart J. 2001;22:518.
- Ouchi Y, Akashita M, De Souza AC, Nakamura T, Orimo H. Age-related loss of bone mass and aortic/aortic valve calcification-reevaluation of recomended dietary allowance of calcium in the elderly. Ann NY Acad Sci. 1993;676:297-307.
- Manna DL, Young JB. Bascia mechanism in congestive heart failure. Recognising the role proinflamatory cytokines. Chest. 1994;105:897-904.
- Sun T, Wang X, Liu Z, Chen X, Zang J. Plasma concentrations of pro- and anti-inflammatory cytokines and outcome prediction in elderly hip fracture patients. Injury. 2011;42(7):707-713.
- Inoue T, Komoda H, Nokana M, Nonaka M, Kameda M, Uchida T, Node K. Interleukin-8 as an independent predictor of long-term clinical outcome in patient with coronary artery disease. Int J Cardiol. 2008;124:319-325.
- Kim CS, Park HS, Kawada T, Kim JH, Lim D, Hubbard NE. Circulation with levels of MCP-1 and IL-8 are elevated in human obese subject and associated with obesity-related parameters. Int J Obes(Lond). 2006;30:1347-1355.
- Zhou RH, Shi Q, Gao HQ, Shen BJ. Changes in serum IL-8 and IL-12 levels in patient with ischemic heart disease in a Chinese population. J Atheroscler Thromb. 2001;8:30-32.
- Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. IL-10 and related cytokines and receptors. Annu Rev Immunol. 2004;22:929-979.
- Caidahl K, Ueland T, Aurrust P. Osteoprotegerin: a biomarker with many faces. Atherosclerosis, Thrombosis Vasc Biol. 2010;30(9):1684-1686.
- Morony S, Tintut J, Zhang Z, Cattley RC, Van G, Dwyer D, Stolina M, Kostenuik PJ, Demer LL. Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in IdIr (–/–) mice. Circulation. 2008;117(3):411-420.